Knut Brockow Selected Research

Knut Brockow Research Topics

Disease

61	Hypersensitivity (Allergy) 11/2022 - 01/2002
46	Anaphylaxis (Anaphylactic Shock) 11/2022 - 01/2004
19	Mastocytosis 01/2022 - 01/2002
15	Drug Hypersensitivity (Drug Allergy) 11/2022 - 01/2002
7	Exercise-Induced Allergies 01/2022 - 04/2015
7	Systemic Mastocytosis 01/2022 - 08/2003
7	Atopic Dermatitis (Atopic Eczema) 01/2021 - 01/2002
6	Neoplasms (Cancer) 01/2022 - 08/2003
5	COVID-19 11/2022 - 11/2020
5	Asthma (Bronchial Asthma) 10/2021 - 01/2010
4	Immediate Hypersensitivity 11/2022 - 01/2006
4	Food Hypersensitivity (Food Allergy) 10/2022 - 01/2020
4	Mast Cell Activation Syndrome 01/2022 - 01/2013
4	Chronic Urticaria 01/2022 - 01/2011
4	Mast Cell Activation Disorders (Mast-Cell Disease) 01/2022 - 08/2012
4	Hereditary alpha-tryptasemia syndrome 01/2022 - 11/2020
3	Osteoporosis 01/2021 - 01/2002
3	Inflammation (Inflammations) 11/2020 - 05/2006
2	Urticaria (Hives) 01/2022 - 01/2021
2	Allergic Rhinitis 10/2021 - 01/2020
2	Syphilis 04/2021 - 01/2021
2	Exanthema (Rash) 11/2020 - 01/2020
2	Bites and Stings (Sting) 01/2020 - 01/2019
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 01/2008
2	Eosinophilic Esophagitis 01/2020 - 08/2014
1	Reinfection 11/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2022
1	Eosinophilia 02/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Disease Susceptibility (Diathesis) 01/2022
1	Herpes Zoster 01/2021
1	red meat allergy 01/2021
1	Mumps 01/2021
1	Rubella (German Measles) 01/2021
1	Pruritus (Itching) 01/2021
1	Measles 01/2021
1	Chickenpox 01/2021

Drug/Important Bio-Agent (IBA)

32	Immunoglobulin E (IgE)IBA 10/2022 - 01/2002
20	Tryptases (Tryptase)IBA 01/2022 - 01/2002
18	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
16	Contrast MediaIBA 07/2022 - 04/2005
12	VaccinesIBA 11/2022 - 11/2012
12	AllergensIBA 01/2022 - 01/2004
9	Arthropod VenomsIBA 01/2022 - 01/2004
8	Biological ProductsIBA 01/2022 - 01/2002
6	COVID-19 VaccinesIBA 11/2022 - 01/2021
6	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2014
5	LactamsIBA 01/2022 - 10/2014
4	beta-LactamsIBA 11/2022 - 01/2020
4	Penicillins (Penicillin)FDA Link 01/2022 - 01/2020
4	Glutens (Glutelin)IBA 01/2022 - 04/2015
4	GliadinIBA 08/2021 - 04/2015
3	mRNA VaccinesIBA 11/2022 - 01/2022
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
3	Coloring Agents (Dyes)IBA 01/2022 - 08/2014
3	EpitopesIBA 01/2022 - 09/2020
3	Omalizumab (Xolair)FDA Link 01/2022 - 01/2020
3	Epinephrine (Adrenaline)FDA LinkGeneric 03/2021 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2005
3	AntibodiesIBA 09/2020 - 01/2004
3	VenomsIBA 01/2020 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2022
2	4'-N,N-dimethylamino-4-aminoazobenzeneIBA 01/2021 - 01/2014
2	dupilumabIBA 01/2021 - 01/2021
2	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2020 - 01/2020
2	SteroidsIBA 01/2020 - 08/2014
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2010
2	GadoliniumIBA 08/2014 - 08/2011
2	Eosinophil Cationic ProteinIBA 08/2014 - 01/2003
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2014 - 01/2010
2	Peptide Hydrolases (Proteases)FDA Link 01/2008 - 05/2006
2	CytokinesIBA 01/2008 - 05/2006
2	Interleukin-6 (Interleukin 6)IBA 05/2005 - 01/2002
1	Monoclonal AntibodiesIBA 02/2022
1	S63845IBA 02/2022
1	venetoclaxIBA 02/2022
1	Tyrosine Kinase InhibitorsIBA 02/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	CosmeticsIBA 01/2022
1	gluteninIBA 08/2021
1	Histamine Receptors (Histamine Receptor)IBA 03/2021
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2021
1	GelatinIBA 01/2021
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2021
1	CarbohydratesIBA 01/2021
1	Blocking AntibodiesIBA 11/2020
1	Infliximab (Remicade)FDA Link 09/2020

Therapy/Procedure

21	Therapeutics 01/2022 - 10/2004
4	Premedication 01/2022 - 04/2005
4	Injections 01/2022 - 09/2019
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
2	Immunotherapy 01/2010 - 01/2004
1	Precision Medicine 11/2020
1	Off-Label Use 11/2020